The recombinant zoster vaccine protects against HZ and PHN in older patients with RA, with no increased risk for RA flares found within 30 days of vaccination.
A systematic review highlights AI’s growing role in diagnosing and predicting vasculitis outcomes, with promising accuracy in Kawasaki disease. Learn more about these advancements.